Parameter | Point-based planning (point A) (Gy) | Volume-based planning (Gy) | P-value |
VR dose per fraction | 8.2 ± 1.5 | 7 ± 1.7 | <0.001 |
VL dose per fraction | 8.1 ± 1.5 | 6.8 ± 1.7 | <0.001 |
VR dose per fraction in EQD2 | 19 ± 5.6 | 15.6 ± 6.1 | <0.001 |
VL dose per fraction in EQD2 | 18.6 ± 5.5 | 13.7 ± 5.8 | <0.001 |
Cumulative VR dose in EQD2 | 119.4 ± 19.3 | 101.5 ± 18.4 | <0.001 |
Cumulative VL dose in EQD2 | 117.5 ± 18.8 | 98.2 ± 18 | <0.001 |
Maximal vaginal-point dose in EQD2 | 121.6 ± 19.8 | 101.1 ± 19.4 | <0.001 |